Home › Insufficienza cardiaca › Virginia › Richmond
Studi clinici su Insufficienza cardiaca a Richmond, VA
16 studi su Insufficienza cardiaca cercano partecipanti presso sedi a Richmond e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
In reclutamentoFase 3
- Research Site, Midlothian · a 11 mi di distanza
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
In reclutamentoFase 3
- Richmond, VA Investigative Site 10069, Richmond
- Richmond, VA Investigative Site 10067, Richmond
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
In reclutamento
- Virginia Commonwealth University, Richmond
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
In reclutamentoStudio osservazionale
- VCU Medical Center, Richmond
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
In reclutamentoFase 3
- Virginia Commonwealth University, Richmond
CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)
In reclutamento
- Richmond VA Medical Center, Richmond, VA, Richmond
Assessment of CCM in HF With Higher Ejection Fraction
In reclutamento
- Bon Secours St. Mary's, Richmond
- Bon Secours St. Mary's, Richmond
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
In reclutamentoFase 3
- FIN-10093, Richmond, VA, Richmond
Treating Heart Dysfunction Related to Cancer Therapy With Sacubitril/Valsartan
In reclutamentoFase 1/2
- Virginia Commonwealth University, Richmond
Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
In reclutamentoFase 3
- Virginia Commonwealth University, Richmond
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
In reclutamento
- HCA Chippenham Medical Center, Richmond
His-Bundle Corrective Pacing in Heart Failure
In reclutamento
- Virginia Commonwealth University, Richmond
Prospective Observational Study of the ICD in Sudden Cardiac Death Prevention
In reclutamentoStudio osservazionale
- Virginia Commonwealth University School of Medicine, Richmond
Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial
In reclutamentoFase 2/3
- Hunter Holmes McGuire VA Medical Center, Richmond, VA, Richmond
Left vs Left Randomized Clinical Trial
In reclutamento
- Virginia Commonwealth University, Richmond
Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator
In reclutamentoFase 4
- Virginia Commonwealth University, Richmond
Studi su Insufficienza cardiaca in altre città
- New York City, NY51 studi
- Boston, MA44 studi
- Dallas, TX42 studi
- Houston, TX36 studi
- Cleveland, OH33 studi
- Chicago, IL31 studi
- Philadelphia, PA31 studi
- San Francisco, CA29 studi
- St. Louis, MO26 studi
- Durham, NC26 studi
- Kansas City, MO25 studi
- Atlanta, GA25 studi
Altri studi a Richmond
- Cancro al seno26 studi
- Cancro del polmone non a piccole cellule25 studi
- Cancro alla prostata19 studi
- Cancro ai polmoni14 studi
- Cancro colorettale13 studi
- Malattie cardiovascolari13 studi
- Malattia epatica steatosica12 studi
- Leucemia mieloide acuta12 studi
- Carcinoma a cellule squamose della testa e del collo12 studi
- Cancro metastatico12 studi
- Melanoma11 studi
- Obesità11 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.